ANG Lifesciences India Limited (BOM:540694)
29.85
-1.57 (-5.00%)
At close: Aug 17, 2026
ANG Lifesciences India Revenue
ANG Lifesciences India had revenue of 154.05M INR in the quarter ending June 30, 2026, a decrease of -37.39%. In the fiscal year ending March 31, 2025, ANG Lifesciences India had annual revenue of 928.47M, down -36.45%.
Revenue
928.47M
Revenue Growth
-36.45%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
412
Market Cap
389.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 928.47M | -532.63M | -36.45% |
| Mar 31, 2024 | 1.46B | -737.81M | -33.55% |
| Mar 31, 2023 | 2.20B | -1.34B | -37.94% |
| Mar 31, 2022 | 3.54B | 2.00B | 129.50% |
| Mar 31, 2021 | 1.54B | 275.48M | 21.72% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.68B |
| JFL Life Sciences | 1.31B |
| Walpar Nutritions | 757.46M |
| Shelter Pharma | 731.34M |
| Sandu Pharmaceuticals | 696.24M |
| Panjon | 493.13M |